Immunotherapy research in the Arab world: A bibliometric analysis

IF 1.6 4区医学 Q4 IMMUNOLOGY

Transplant immunology Pub Date : 2025-03-16 DOI:10.1016/j.trim.2025.102218

Ahmad Afyouni , Jana Kotaich , Sara Sarout , Amarelle Chamoun , Georgia Chkayban , Saad El Hariri , Tarek Baroud , Adnan Fatfat , Jad El Masri , Pascale Salemeh

{"title":"Immunotherapy research in the Arab world: A bibliometric analysis","authors":"Ahmad Afyouni , Jana Kotaich , Sara Sarout , Amarelle Chamoun , Georgia Chkayban , Saad El Hariri , Tarek Baroud , Adnan Fatfat , Jad El Masri , Pascale Salemeh","doi":"10.1016/j.trim.2025.102218","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Immunotherapy is the concept of leveraging the immune system to treat diseases. Developing countries, including the Arab countries, have continued to lag in terms of biomedical research compared to other nations for several decades. Immunotherapy has been used in several fields, including cancer, transplantation, and vaccination. This article examined the activity and trend of immunotherapy research in the Arab world between 2000 and 2024.</div></div><div><h3>Methods</h3><div>The number of immunotherapy-related articles published by each Arab country, was assessed using the PubMed database between 2000 and 2024. Numbers were normalized with respect to each country's average population and average Gross Domestic Product (GDP).</div></div><div><h3>Results</h3><div>Arab countries contributed to 1.73 % of total immunotherapy papers. The number of immunotherapy publications has grown from 2000 to 2022, then decreased in the past 2 years. In terms of publications per million persons, Qatar ranked first (130.08 per million persons), while in terms of publications per national GDP, Lebanon ranked first (11.09 per billion US dollars). MeSH keywords VOSviewer showed a focus on vaccination, COVID-19, COVID-19 vaccines, and transplantation conditioning in the Arab world.</div></div><div><h3>Conclusions</h3><div>This bibliometric analysis provides insight into the actualities and trends of immunotherapy research in the Arab world. This offers a general background for scientists, clinicians, funders, and decision-makers. Addressing the barriers that face immunotherapy research remains a cornerstone in the plan to improve the Arab world's output and contribution to this field.</div></div>","PeriodicalId":23304,"journal":{"name":"Transplant immunology","volume":"90 ","pages":"Article 102218"},"PeriodicalIF":1.6000,"publicationDate":"2025-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplant immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0966327425000462","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Immunotherapy is the concept of leveraging the immune system to treat diseases. Developing countries, including the Arab countries, have continued to lag in terms of biomedical research compared to other nations for several decades. Immunotherapy has been used in several fields, including cancer, transplantation, and vaccination. This article examined the activity and trend of immunotherapy research in the Arab world between 2000 and 2024.

Methods

The number of immunotherapy-related articles published by each Arab country, was assessed using the PubMed database between 2000 and 2024. Numbers were normalized with respect to each country's average population and average Gross Domestic Product (GDP).

Results

Arab countries contributed to 1.73 % of total immunotherapy papers. The number of immunotherapy publications has grown from 2000 to 2022, then decreased in the past 2 years. In terms of publications per million persons, Qatar ranked first (130.08 per million persons), while in terms of publications per national GDP, Lebanon ranked first (11.09 per billion US dollars). MeSH keywords VOSviewer showed a focus on vaccination, COVID-19, COVID-19 vaccines, and transplantation conditioning in the Arab world.

Conclusions

This bibliometric analysis provides insight into the actualities and trends of immunotherapy research in the Arab world. This offers a general background for scientists, clinicians, funders, and decision-makers. Addressing the barriers that face immunotherapy research remains a cornerstone in the plan to improve the Arab world's output and contribution to this field.

查看原文本刊更多论文

阿拉伯世界的免疫治疗研究：文献计量学分析

免疫疗法是利用免疫系统来治疗疾病的概念。几十年来，包括阿拉伯国家在内的发展中国家在生物医学研究方面继续落后于其他国家。免疫疗法已应用于多个领域，包括癌症、移植和疫苗接种。本文考察了2000年至2024年间阿拉伯世界免疫治疗研究的活动和趋势。方法使用PubMed数据库对2000年至2024年间每个阿拉伯国家发表的免疫治疗相关文章的数量进行评估。这些数字是根据每个国家的平均人口和平均国内生产总值（GDP）进行标准化的。结果非洲国家占免疫治疗论文总数的1.73%。免疫治疗出版物的数量从2000年增长到2022年，然后在过去两年中下降。在每百万人的出版物方面，卡塔尔排名第一（每百万人130.08），而在每国民生产总值的出版物方面，黎巴嫩排名第一（每十亿美元11.09）。MeSH关键词VOSviewer重点关注阿拉伯世界的疫苗接种、COVID-19、COVID-19疫苗和移植调节。结论文献计量分析提供了对阿拉伯世界免疫治疗研究现状和趋势的洞察。这为科学家、临床医生、资助者和决策者提供了一般的背景知识。解决免疫治疗研究面临的障碍仍然是提高阿拉伯世界在这一领域的产出和贡献的计划的基石。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Transplant immunology 医学-免疫学

CiteScore

2.10

自引率

13.30%

发文量

198

审稿时长

48 days

期刊介绍： Transplant Immunology will publish up-to-date information on all aspects of the broad field it encompasses. The journal will be directed at (basic) scientists, tissue typers, transplant physicians and surgeons, and research and data on all immunological aspects of organ-, tissue- and (haematopoietic) stem cell transplantation are of potential interest to the readers of Transplant Immunology. Original papers, Review articles and Hypotheses will be considered for publication and submitted manuscripts will be rapidly peer-reviewed and published. They will be judged on the basis of scientific merit, originality, timeliness and quality.